Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
65.00
-1.22 (-1.84%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Belite Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-36.14-31.63-12.65-9.67-5.75
Depreciation & Amortization
0.450.40.20.030.02
Loss (Gain) From Sale of Assets
----0.01-
Loss (Gain) From Sale of Investments
-0.05----
Stock-Based Compensation
8.993.821.481.531.36
Other Operating Activities
-3.61----
Change in Accounts Receivable
0.02-0.02-0.03-0
Change in Accounts Payable
0.01--0.040.05-0.02
Change in Other Net Operating Assets
1.1-2.41-0.420.6-0.05
Operating Cash Flow
-29.23-29.84-11.46-7.47-4.44
Capital Expenditures
-0.12-0.06-0.39-0.07-0.02
Sale of Property, Plant & Equipment
---0.02-
Sale (Purchase) of Intangibles
-0.04----
Investment in Securities
-110.42----
Investing Cash Flow
-110.57-0.06-0.39-0.06-0.02
Short-Term Debt Issued
----0.13
Total Debt Issued
----0.13
Short-Term Debt Repaid
-----2.45
Total Debt Repaid
-----2.45
Net Debt Issued (Repaid)
-----2.32
Issuance of Common Stock
58.277.1937.990.230.59
Other Financing Activities
25.39-1.23-1.03-0.82-
Financing Cash Flow
83.675.9636.96-0.5828.06
Foreign Exchange Rate Adjustments
-0.270.01-0.37-0.160
Net Cash Flow
-56.4846.0724.75-8.2723.6
Free Cash Flow
-29.35-29.9-11.85-7.55-4.46
Free Cash Flow Per Share
-0.96-1.12-0.59-0.79-0.51
Cash Interest Paid
--0.02-0.02
Cash Income Tax Paid
0.010.01---
Levered Free Cash Flow
-13.42-15.3-7.1-4.01-
Unlevered Free Cash Flow
-13.4-15.28-7.09-4.01-
Change in Net Working Capital
-2.31-0.350.36-0.63-
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q